Associate Director, Commercial Operations, Germany

The role

The Associate Director, Commercial Operations will prepare Acadia Pharmaceuticals Germany for the launch of a new rare disease product for Rett syndrome. This role supports commercial strategy, launch readiness, cross-functional execution, and performance tracking in the German market.

What you will do

• Support development of launch strategy, commercial planning, and business planning for Germany.
• Define goals, strategies, tactics, and market analyses for a new rare disease product.
• Oversee marketing and launch activities including brand, PR, digital plans, forecasting, and demand planning.
• Track launch performance and support commercial and field force excellence initiatives.
• Coordinate cross-functional alignment across medical, marketing, PR, digital, market access, and reimbursement.
• Support customer-facing execution, CRM, territory management, ROI evaluation, and budget allocation.
• Partner with the EU Commercial team and GM Germany on commercial priorities.
• Lead local sales and marketing meetings and cross-functional project groups.
• Operate in line with ethical standards and company procedures.

Required qualifications

• Master’s degree in science, healthcare, business, or a relevant field
• 5–7 years of experience in a specialty indication, such as neuroscience
• Broad commercial experience across marketing, PR, digital, sales, and business intelligence
• English proficiency, both written and spoken

Nice to have

• Experience in a rare disease care environment

Benefits

• Competitive base, bonus, new hire and ongoing equity packages
• Medical, dental, and vision insurance
• Employer-paid life, disability, business travel and EAP coverage
• 401(k) Plan with a fully vested company match 1:1 up to 5%
• Employee Stock Purchase Plan with a 2-year purchase price lock-in
• 15+ vacation days
• 13 -15 paid holidays, including office closure between December 24th and January 1st
• 10 days of paid sick time
• Paid parental leave benefit
• Tuition assistance

About the company

Acadia is committed to turning scientific promise into meaningful innovation for underserved neurological and rare disease communities. Their commercial portfolio includes the first and only FDA-approved treatments for Parkinson’s disease psychosis and Rett syndrome.